ADCT•prnewswire•
ADC Therapeutics to Participate in the 44th Annual J.P. Morgan Healthcare Conference
Summary
LAUSANNE, Switzerland, Jan. 8, 2026 /PRNewswire/ -- ADC Therapeutics SA (NYSE: ADCT), a commercial-stage global leader and pioneer in the field of antibody drug conjugates (ADCs), today announced that Ameet Mallik, Chief Executive Officer, will present at the 44th Annual J.P. Morgan...
Original Article
Read the full article from the original source for complete details and context.
Read Full ArticleArticle published on January 8, 2026 by prnewswire